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AbstrACt
Introduction Many people living with advanced dementia 
live and die in nursing care homes. The quality of life, care 
and dying experienced by these people is variable. Namaste 
Care is a multisensory programme of care developed for 
people with advanced dementia. While there is emerging 
evidence that Namaste Care may be beneficial for people 
with dementia, there is a need to conduct a feasibility study 
to establish the optimum way of delivering this complex 
intervention and whether benefits can be demonstrated in 
end-of-life care, for individuals and service delivery. The aim 
of the study is to ascertain the feasibility of conducting a full 
trial of the Namaste Care intervention.
Methods and analysis A feasibility study, comprising a 
parallel, two-arm, multicentre cluster controlled randomised 
trial with embedded process and economic evaluation. 
Nursing care homes (total of eight) who deliver care to 
those with advanced dementia will be randomly allocated 
to intervention (delivered at nursing care home level) or 
control. Three participant groups will be recruited: residents 
with advanced dementia, informal carers of a participating 
resident and nursing care home staff. Data will be collected 
for 6 months. Feasibility objectives concern the recruitment 
and sampling of nursing homes, residents, informal carers 
and staff; the selection and timing of primary (quality of dying 
and quality of life) and secondary clinical outcome measures 
(person centredness, symptom presence, agitation, quality of 
life, resource use and costs and residents’ activity monitored 
using actigraphy). Acceptability, fidelity and sustainability 
of the intervention will be assessed using semistructured 
interviews with staff and informal carers.
Ethics and dissemination This protocol has been 
approved by NHS Wales Research Ethics Committee 5 (ref: 
17/WA0378). Dissemination plans include working with a 
public involvement panel, through a website (http://www. 
namastetrial. org. uk), social media, academic and practice 
conferences and via peer reviewed publications.
trial registration number ISRCTN14948133; Pre-results.
IntroduCtIon 
background
Dementia is a life-limiting condition, with 
a median survival, decreasing with age, of 
6.7–1.9 years.1 In advanced dementia, an 
individual requires full assistance with care 
is chair or bedbound, doubly incontinent 
and no longer able to communicate verbally 
(Functional Assessment of Staging of Alzhei-
mer’s Disease (FAST) scale 6–7).2 People with 
dementia often experience a poor quality of 
death, preceded by a period of poor quality 
of life, with over and under treatment occur-
ring.3–5 There is an increasing urgency for 
appropriate care that will ensure a good 
quality of life and dying are achieved.5 6 
Evidence for therapeutic healthcare inter-
ventions for people with advanced dementia 
is limited. Reviews of therapies such as 
music therapy indicate mixed outcomes 
for people with dementia, with a Cochrane 
review identifying equivocal evidence.7 
More recent reviews of therapeutic interven-
tions have identified large positive effects 
on behavioural, cognitive and physiological 
outcomes,8 to moderate effects on anxiety 
with small effects on behavioural symptoms 
strengths and limitations of this study
 ► Intervention trialled is based on a theoretical model 
of how the intervention works, drawn from current 
evidence base and consultation with care home 
staff, family and experts.
 ► Public and Patient Involvement (PPI) will greatly in-
form the ongoing development of the research de-
sign and delivery and assist in recruitment, analysis 
and dissemination.
 ► Both proxy and objective measures will be mea-
sured with this hard to research population.
 ► Blinding is not possible due to the nature of the 
intervention.
 ► The study will not provide data on the effectiveness 
of the intervention, but will indicate if a further trial 
to establish effectiveness is feasible.
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and evidence for short-term improvement in mood and 
reduction in behavioural disturbance.9 10 In a Cochrane 
review of touch therapies, some evidence of an effect was 
identified, but not specifically for people with advanced 
dementia.11 A recent review indicated that massage 
reduced levels of agitation.12 Interventions supporting 
person-centred care have been shown to reduce agitation 
and behavioural disturbance. There is some evidence for 
individualised interventions, within a bio-psychosocial 
framework, improving behavioural symptoms.13–15
Interventions with a single focus on reducing pain, 
physical symptoms or specific behavioural disturbances 
have been found to be effective.3 It is recognised that for 
people with advanced dementia there is a need for inter-
ventions that complement and enhance pharmacological 
interventions. This study addresses the lack of evidence 
available through completed research, to consider the 
stage-specific efficacy of non-pharmacological interven-
tions.16 There is also a need for practical interventions 
that staff can learn to deliver which allow them to provide 
person-centred care.
Palliative and end-of-life care interventions for people 
with dementia that emphasise a person-centred philos-
ophy, and use co-design approaches, are being developed 
and tested.17 Namaste Care is one such intervention. 
Non-randomised research studies have identified that 
Namaste Care at the end of life reduces the severity of 
behavioural and physical symptoms and occupational 
disruptiveness and may have an impact on social inter-
action, delirium and agitation.18–22 The potential for cost 
savings with respect to reduced psychotropic medication 
use has also been indicated.19 23 Qualitative evidence 
suggests greater family and staff satisfaction with care.18 
However, none of these studies have compared this inter-
vention with other approaches to palliative and end-of-
life care for this population. We do not yet know the 
optimum way of delivering this complex intervention 
and which benefits (including cost-effectiveness) can 
be demonstrated in end-of-life care, for individuals and 
service delivery.
In Phase i of this study, a realist review of 85 papers that 
considered Namaste Care and sensory interventions (such 
as music therapy or massage) for people with advanced 
dementia identified three context–mechanism–outcome 
configurations. This indicated what needs to be in place 
for Namaste Care to work for this population. The over-
arching theme was the importance of providing activities 
that enabled the development of moments of connec-
tion for people with advanced dementia. This can occur 
when the following three elements are in place: provi-
sion of structured access to stimulation (social and phys-
ical), equipping care home staff to be able to cope with 
complex variable behaviours and providing a framework 
for person-centred care.
Intervention development
The Namaste Care intervention is already promoted using 
existing resources.24 25 In this study, a four-stage approach 
to the development and refinement of the interven-
tion resources was used. This entailed (1) collating the 
existing intervention materials and the findings of the 
realist review to draft an intervention description; (2) 
exploring the readability, comprehensibility and utility 
of the materials with staff unfamiliar with Namaste Care; 
(3) using a modified nominal group techniques with 
people with Namaste Care experience to refine and 
prioritise the intervention implementation materials; and 
(4) final refinement with the study’s patient and public 
involvement panel. This led to production of a 16-page 
A4 booklet. The booklet included the use of flow charts, 
graphics and colour-coded information supported by 
infographics, and a training package.
Therefore, we propose undertaking a feasibility cluster 
controlled randomised trial in a nursing care home 
context between 1 January 2018 to 31 March 2019.
Aims and objectives
The primary objective of this feasibility study is to ascer-
tain the feasibility of conducting a full trial of the Namaste 
Care intervention.
The feasibility issues associated with the research design 
and data collection processes to enable the design of a 
full trial to determine the efficacy of Namaste Care are
a. To understand how best to sample and recruit nurs-
ing homes into a cluster randomised controlled trial 
of Namaste Care. 
b. To determine the most appropriate selection, timing 
and administration of primary and secondary outcome 
measures for a full cluster randomised controlled trial 
of Namaste Care against criteria of bias minimisation, 
burden and acceptability. 
c. To establish recruitment, retention and attrition rates 
at the level of the nursing home and individual resi-
dent, informal carer and nursing home staff. 
d. To establish the willingness of a large number of nurs-
ing homes representing the range of nursing homes, 
with respect to provider type, size, resident care needs, 
to participate in a full trial.
e. To assess the acceptability, fidelity and sustainability of 
the Namaste Care intervention.
Secondary objectives include resident levels of sleep/
activity, neuropsychiatric symptoms and pain, informal 
carer satisfaction with care at the end-of-life staff care 
giving experiences and satisfaction with care in end-of-
life care. Health economic and healthcare resource use 
will also be assessed.
MEthods And AnAlysIs
trial design
A feasibility study consisting of a parallel, two-arm, multi-
centre cluster controlled randomised trial design with an 
embedded process evaluation is to be conducted. The 
clustering will take place at the nursing care home level. 
The Namaste Care programme in the intervention arm 
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will be compared with the standard programme of care 
used in the control homes.
study population
Nursing care homes
Eight nursing care homes based in the northwest of 
England already using a recognised palliative care 
programme (eg, Gold Standards Framework for Care 
Homes, Six Steps to Success or equivalent) will be 
recruited into the study. Two nursing care homes will be 
allocated to the control arm while six nursing care homes 
will be allocated to the intervention arm. To meet the 
eligibility criteria, the nursing care home needs to have
1. At least 30 beds.
2. Six residents who meet the resident eligibility criteria.
3. The space to run the Namaste Care programme.
4. A manager or a nominated person to act as the princi-
pal investigator.
A nursing care home will not be eligible to join the 
study if they
1. Are rated as needs improvement or inadequate in the 
latest Care Quality Commission (CQC) inspection.
2. Are subject to (CQC)enforcement notices.
3. Have already introduced Namaste Care in their nurs-
ing care home.
4. Are currently involved in another research study that 
conflicts with this study.
Individual participants
Residents: To meet the resident eligibility criteria, a resi-
dent has to
1. Be a permanent resident living in the participating 
nursing care home.
2. Lack mental capacity.
3. Have a formal assessment of advanced dementia based 
on the FAST score of 6–7 made by the nursing care 
home manager or another experienced member of 
staff.
4. Have a key worker member of staff willing to complete 
outcome tools.
A resident will be ineligible to participate in the study 
if the resident
1. Is permanently bedbound.
2. Is currently or has recently been involved in another 
research study that conflicts with Namaste Care or with 
data collection during the course of the Namaste Care 
study.
Informal carer: To meet the informal carer eligibility 
criteria, a person who
1. Is 18 years and over.
2. Can communicate in English.
3. Self-defines as a relative or a friend and acts a carer for 
a resident enrolled to take part in the study.
A person will not be eligible to participate in the study if
1. Their relative or friend is a resident and has not been 
enrolled in to the study.
Nursing care home staff: To meet the nursing care 
home eligibility criteria, a person has to be
1. A member of health and social care staff paid to pro-
vide care to residents with advanced dementia within 
participating nursing care homes.
Nursing care home staff will not be eligible to partici-
pate in the study if
1. They are in the intervention arm and they have deliv-
ered the Namaste Care programme or cared for resi-
dents receiving Namaste Care in a nursing care home 
not involved in this study.
Sample size and selection
As the aim of this study is to establish feasibility of a full 
trial, a formal sample size calculation was not carried out. 
A sample size of eight nursing homes (six interventions 
and two controls) has been selected as it offers a reason-
able test of the intervention to assess the feasibility objec-
tives. There have been a range in the sample sizes used 
in feasibility studies in nursing homes ranging from 2266 
to 14.27
Eligible nursing care homes will be identified 
through online resources such as the ENRICH data-
base. Following the initial identification, contact will be 
made with managers of the nursing care home to discuss 
the study and confirm the eligibility of the nursing care 
home. Consent for the homes will be assumed when the 
manager of the facility signs a contract drawn up by the 
sponsor, Lancaster University.
randomisation
The randomisation of participating nursing care homes 
to either the intervention arm or the control arm will 
be undertaken by statisticians from the Clinical Trials 
Research Centre (CTRC) at the University of Liverpool 
randomisation team who will not be involved in the study. 
Due to the clustered randomisation approach of this 
study, all study participants will be assigned to the same 
study arm as the nursing care home they are associated 
with. The nature of the intervention and its delivery 
means that it will not be possible to blind nursing homes 
or staff to the allocation status. If possible, to minimise 
potential for bias, staff involved in the delivery of the 
Namaste Care intervention will not be involved in the 
completion of outcome measures. It will not be possible 
to blind researchers to the allocation of nursing homes as 
the intervention requires changes to the nursing home 
environment which may be visible to any researcher 
visiting the facility.
The study flow chart of activities (figure 1) show the 
recruitment process to be followed.
Consent procedures
Individual participants
Residents: Potentially eligible residents will be screened 
by the principal investigator and the senior care team 
at each nursing care home. Consent for the eligible 
residents will be sought from a personal consultee of 
the resident in the first instance. If a person consultee 
does not reply within month of been given the invitation 
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Figure 1 Flow diagram outlining the process of the study.
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pack, then assent will be taken from either a nominated 
consultee or the process used by the nursing care home 
in question. Once permission is granted by the personal 
consultee, members of the research team will discuss the 
study with the personal consultee and gain assent for resi-
dents to take part in the study. Process consent will also be 
considered for the resident participant group.28 There-
fore, if a resident shows signs of not wanting to take part 
in the Namaste Care session they will be allowed to miss 
the Namaste Care session and still continue in the trial.
Informal carer: The informal carers of residents 
enrolled to the study will be identified by the principal 
investigator and the senior care team at each nursing care 
home and invited to consent to complete questionnaires 
and participate in a qualitative interview.
Nursing care home staff: Nursing care home staff inter-
ested in taking part in the Namaste Care study will be 
identified by the nursing care home manager. On identi-
fication, researchers will discuss the study with the identi-
fied staff members and obtain written consent from each 
staff member.
A research lead will be appointed in each nursing care 
home. The research lead will be tasked with ensuring the 
paperwork associated with clinical research and the Inves-
tigator Site File is maintained. The research lead and the 
principal investigator from the intervention sites and the 
control sites will be invited to a training day for guidance 
on selection of participants and completion of data collec-
tion forms and maintaining the Investigator Site File.
Participants will be followed for 6 months after the 
commencement of the Namaste Care intervention in 
each nursing care home in the intervention arm or after 
the recruitment of the first four residents in the nursing 
care home for sites in the control arm.
Intervention
The intervention is a programme of care (Namaste Care), 
delivered in the intervention care homes by care staff 
working in the facility. The following description uses the 
TIDieR guidelines for intervention description (items 
1–9).29
Namaste Care seeks to give comfort and pleasure to 
people with advanced dementia through engagement, 
meaningful and creative activities as well as sensory stim-
ulation to reflect the resident’s ‘life story’.24 Supporting 
resource materials have been developed which provide 
the following guidance regarding the implementation of 
Namaste Care programme.
 ► The Namaste Care sessions should be undertaken 
within a designated space in the nursing home. This 
space could be within another room or a room which 
is used for other purposes.
 ► The environment of the designated space must be 
made ‘special’ and should enable a feeling of calm 
that is welcoming and homely, with natural or slightly 
dimmed lighting, perhaps attractive scents, such as 
lavender from an aromatherapy diffuser, and with soft 
music playing.
 ► The Namaste Care sessions should be undertaken in 
a group setting.
 ► Food and drink should be offered to the residents.
 ► A minimum of two nursing home staff members or 
volunteers should be present to run the Namaste Care 
sessions.
 ► The duration and frequency of Namaste Care delivery 
as proposed by its originator (2 hours a day, twice a 
day, 7 days a week) will be promoted.24
Namaste Care champions will be appointed in each 
nursing care home in the intervention arm. At least two 
care staff (registered nurses, care assistants or activity 
coordinators) will attend a 1-day workshop about 
Namaste Care, led by an experienced external facilitator. 
A follow-up training session will be held at each nursing 
care home to train more staff and provide advice on 
preparing the Namaste space.
Prior to the commencement of enrolment, Namaste 
Care champions (eligible nursing care homes will be 
identified in the intervention arm) will be appointed in 
each nursing care home. The Namaste Care champion 
will be invited to a training day for guidance on Namaste 
Care intervention, held at a site away from nursing care 
homes and undertaken by members of the research team 
and an external trainer. A follow-up training session will 
be held at each nursing care home.
Control arm
The care home manager of nursing care homes allocated 
to the control arm will be asked to continue delivering 
the usual care programme used in their facility.
Training on the Namaste Care programme will be avail-
able to the nursing care homes in the control arm after 
the study has been completed.
outcome and study measures
We consider two contender primary outcomes for a full 
trial: (1) quality of dying (dementia) (CAD-EOLD) and 
(2) quality of life (QUALID) (tables 1-4).30 31
The secondary outcome measures in this trial (table 1) 
will measure measure person centredness, symptom pres-
ence, agitation, quality of life, resource use and costs; 
and sleep and activity using actigraphy.32–37Semistruc-
tured interviews with staff and informal carers will assess 
perceptions of Namaste Care or usual care, assessment of 
the fidelity, acceptability and appropriateness of Namaste 
Care or of usual care.
The outcome measures to be used are listed in 
tables 1–4 and presented based on respondent type, 
that is, measures for residents (table 1), informal carers 
(table 2), staff (table 3) and at the level of the nursing 
care home (table 4). At the start of the study, descrip-
tive data will be collected for all participating nursing 
care homes such as ownership and funding model, size, 
staffing, case mix, staff turnover, staff sickness/absence 
and geographical location. An interview with the nursing 
care home manager will also be conducted to ascertain 
the organisation’s readiness for change.
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data collection
In this study, the outcome measures and process evalua-
tion data will be gathered via five different methods:
1. Questionnaires: The nursing home staff participant 
group and the informal carer participant group will be 
asked to complete written questionnaires at timepoints 
Table 1 Summary of resident data collected by care home staff, outcome measures and time schedule
Data collected and tool used
Pre-
intervention Monthly
At 6 months 
or death
Socio-demographics Age, gender, ethnicity, existing 
medical conditions, stage of 
dementia on Functional Assessment 
of Staging of Alzheimer’s Disease 
score
x x x
Quality of dying Measure to assess quality of 
death using CAD-EOLD (Comfort 
Assessment in Dying with 
Dementia)47 48
x x x
Quality of life of the person with 
dementia
EQ-5D-5L38 self-rated health index 
and visual analogue scale of current 
health state
x x x
Neuropsychiatric 
Inventory (Neuropsychiatric 
Inventory–Questionnaire)
Measure to assess psychiatric state 
of resident using NPI-Q39
x x x
Pain Measure to assess level of pain 
using PAIN-AD35
x x x
Quality of life EQ-5D-5L x x x
ICECAP Supportive Care Measure Health economic measure using 
ICEPCAP-SCM39
x x x
ICECAP-O measure (CEpop 
CAPability measure for Older people)
Health economic measure using 
ICEPCAP-O49
x x x –
Cohen-Mansfield Agitation Inventory Measure to assess resident 
agitation36
x x x
ICECAP Supportive Care Measure 
using Think Aloud
Health economic measure using 
ICEPCAP-SCM using Think Aloud
x x x
ICECAP-O measure using Think 
Aloud
Health economic measure using 
ICECAP-O using Think Aloud
x x x
Table 2 Summary of informal carer data collected, as assessed by informal carers, outcome measures and time schedule
Data collected and tool 
used Baseline At 1 month At 6 months or death
Socio-demographics Age, gender, ethnicity, 
existing medical conditions
x – – 
Service use in the prior 
month
Client Service Receipt 
Inventory50 Calculates 
service and total care costs
x x x
Quality of life of the carer EQ-5D-5L x x x
Satisfaction with care SWC-EOLD (Satisfaction 
with Care at the End-of-
Life in Dementia)34
x x x
ICECAP Close Person 
Measure of health economic 
evaluation
Health economic 
evaluation using ICECAP-
CPM
x x x
ICECAP Close Person 
Measure of health economic 
evaluation
Health economic 
evaluation using ICEPCAP-
CPM completing using 
Think Aloud
x x x
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outlined in tables 1–3. The questionnaires for the res-
ident participant group will be proxy completed by 
nursing care home staff who are key workers for the 
participating residents. Note the time frame for base-
line varies depending on the participant group. Data 
on nursing home level data about engagement with 
health and social care services will be collected using 
standardised data collection forms (table 4).
2. Objective measures: The participating residents will be 
asked to wear an actigraph watch-like device for 28 days 
from the baseline visit. This actigraph will be placed on 
the wrist or ankle of the resident and will be used to 
continuously measure sleep and activity.
3. Interviews: Semi structured interviews will be under-
taken at the baseline with the nursing home manager 
and at the end of the data collection period with family 
carers and care staff.
4. Observations of the residents will be undertaken inter-
mittently during the delivery of the care programme 
and during the delivery of usual care in the control 
sites.
5. Data logs will be completed in the intervention sites 
using a proforma to record intervention delivery.
Feasibility work for economic evaluation
The use of a number of potential outcome measures will 
be explored in terms of feasibility and acceptability of 
proxy completion with the particular population, eval-
uated through the Think Aloud technique. The chosen 
measures are included in the National Institute for Health 
and Care Excellence-recommended measures for health 
and social care: EQ-5D-5L (five items), the ICECAP-O 
(five items) and the ICECAP-Supportive Care Measure 
(ICECAP-SCM) (seven items).38–40 A Think Aloud tech-
nique will also be used with the ICECAP-O, ICECAP-SCM 
and ICECAP-CPM tools for a proportion of participants 
at 2, 4 and 24 weeks, to obtain 20–30 Think Aloud inter-
views across a range of timepoints.41 This Think Aloud 
Table 3 Summary of staff data collected as assessed by care home staff: outcome measures and time schedule
Data collected and tool used Preintervention 6 months 
Staff socio-demographics Age, gender, ethnicity X – 
Staff work characteristics Highest qualification, role in care home, length of 
service
X – 
Organisational support for person-centred 
care
The Person-Centred Care Assessment Tool 32 X X 
Organisational support for readiness for 
change
The Alberta Context Tool Questionnaire51 X – 
Table 4 Summary of nursing care home level data collected, outcome measures, time schedule and the type of person 
assessing the outcome measure
Data collected and tool used Pre intervention Monthly At 6 months only Postintervention
Care home occupancy level Number of available beds to new 
residents
S – – – 
Cost of living in the care home Fees to live in the care home S – – – 
Contributions from local government Fees paid by the local government for 
each resident
S – – – 
Staffing levels Number and type of staff S – – – 
Number of GP practices the care home 
works with
Number of GP practices the care home 
works with
S – – – 
Number of GPs the care home works 
with
Number of GPs the care home works 
with
S – – – 
Level of need of residents in the care 
home
Amount of support each resident needs S – – – 
Staff turnover and sickness levels Number of staff in the care home and 
monthly sickness record
S S – – 
Ambulances and hospital use Number and length of hospital 
admissions (days), A&E attendances and 
readmissions
S S S – 
Number of hospital admissions Respiratory infections, urinary tract 
infections, dehydration, congestive heart 
failure?
S S S – 
Out of hours GP contacts GP visits or telephone contact R R R R
Measure assessed by S: care home staff; R: researcher.
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technique will be undertaken either via telephone or 
face to face. The feasibility of collecting resource use data 
through nursing home records will be assessed, and the 
cost of the interventions will be estimated, for use in a full 
evaluation.
Process evaluation
The process evaluation elements of the study (table 5) 
will address staff members’ perceptions of Namaste Care 
(intervention arm) or perceptions of the effectiveness of 
usual care (control arm) using interviews approximately 
24 weeks after the first resident is recruited at the nursing 
home. Family carers’ perceptions of Namaste Care (inter-
vention arm) or carers’ perceptions of the effectiveness 
of usual care (control arm) will be ascertained using 
interviews between 16–24 weeks after the first resident is 
recruited at the nursing home.
To assess the fidelity, acceptability and appropriateness 
of Namaste Care (intervention arm) or assess effectiveness 
of usual care (control arm) observation will be conducted 
at approximately 2, 4 and 24 weeks after the start of the 
intervention for nursing homes in the intervention arm 
and approximately 2 and 4 weeks in the control arm.
A data log will be completed by the staff delivering 
the Namaste Care session throughout the intervention 
delivery.
data management
Data management is provided by the CTRC at the University 
of Liverpool. Paper-based case report forms will be written 
to record data in a consistent way and ensure anonymisa-
tion of the data. Data stored at the CTRC will be checked for 
missing or unusual values (range checks) and checked for 
consistency within participants over time. Any suspect data 
will be returned to the site in the form of data queries. Data 
query forms will be produced at the CTRC from the trial 
database and sent either electronically or through the post 
to a named individual (as listed on the site delegation log). 
Sites will respond to the queries providing an explanation/
resolution to the discrepancies and return the data query 
forms to CTRC. The forms will then be filed along with 
the appropriate data collection forms and the appropriate 
corrections made on the database. The process of database 
lock, unlock and closure will be followed according to the 
CTRC policy.
data analysis plan
Three types of data will be analysed: quantitative date 
from surveys and the actigraphs, qualitative data from 
interviews and economic data.
Quantitative analysis
Outcomes at baseline and follow-up will be summarised 
using descriptive statistics and will be used to make a deci-
sion on undertaking a full trial. Analysis of the outcome 
data will focus on recruitment, response and completion 
rates, and missing data. Reasons for non-consent and 
missing outcome data will be reported. Estimates of SD 
and proxy agreement will be determined, and construct 
validity estimated intracluster correlation coefficient will 
be made.
The sleep/activity data from the actigraph will be 
analysed using summary statistics for the sleep analysis 
data (sleep/wake ratios, total sleep time, sleep effi-
ciency, wake after sleep onset and total activity); partic-
ipant’s rhythm fragmentation and synchronisation will 
be estimated via intradaily variability (IV) and interdaily 
stability (IS).42 43 The actigraph will be used to ascertain 
the feasibility of use this outcome measure to collect 
data in a full trial.
Table 5 Data collected as part of the process evaluation
Outcome measures or rationale for 
data collection Data collected through Time of data collection
To assess carers’ perceptions of Namaste 
Care (intervention arm) or carers’ 
perceptions of the effectiveness of usual 
care (control arm)
Interviews conducted by the researcher Approximately 16–24 weeks after the first 
resident is recruited at the nursing home
(If a resident dies during the trial then the 
informal carer will be approached at least 
8 weeks after the resident’s death)
Staff members’ perceptions of Namaste 
Care (intervention arm) or perceptions of 
the effectiveness of usual care (control 
arm)
Interviews conducted by the researcher Approximately 24 weeks after the first 
resident is recruited at the nursing home
To assess the fidelity, acceptability 
and appropriateness of Namaste Care 
(intervention arm) or assess effectiveness 
of usual care (control arm)
Observations conducted by the 
researcher
Approximately 2, 4 and 24 weeks after 
the start of the intervention for nursing 
homes in the intervention arm
Approximately 2 and 4 weeks after the 
first resident is recruited for nursing 
homes in the control arm
To assess the fidelity, acceptability and 
appropriateness of the Namaste Care 
(intervention arm)
Data log completed by the staff 
delivering the Namaste Care session
Throughout the intervention
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Qualitative analysis
Semistructured interviews will be audio-recorded, tran-
scribed and anonymised. Framework analysis will be 
used in the analysis of qualitative data, with data collec-
tion, management and analysis rigorously conducted to 
enable reporting against COREQ guidelines. Group/
individual interviews and observation sessions will be digi-
tally audio-recorded and fully transcribed. NVivo will be 
used to facilitate data management and analysis as this 
supports framework analysis techniques.
Analysis of economic data
Economic assessments of relevant outcome measures will 
combine qualitative assessments of feasibility of use for the 
outcome measures gained through the think aloud tech-
niques and more quantitative assessments of agreement 
between proxies, and assessments of construct validity for 
the measures.44 Response and completion rates will be 
assessed. Constant comparative analytical methods will be 
used to provide a more in-depth assessment of both the 
questionnaire completion and respondents’ perceptions 
of the measures in the Think Aloud interviews.
Unit cost information will be generated using bottom-up 
costing for the Namaste intervention itself, ensuring that 
a cost for the intervention will be available in a full trial. 
Other sources of unit cost information will be identified 
and collated for use in a future full trial and will be applied 
to the collected resource use data to enable the prelimi-
nary assessment of costs and benefits, and the main cost 
drivers for a full evaluation. All data will be costed using 
unit cost data in pounds sterling, and from a single year, 
as close as possible to the end of the feasibility study.
Public and patient involvement (PPI)
Two carer representatives from the Alzheimer’s Society 
Research Network UK were co-applicants as part of the 
core study/trial management group. They will be present 
at all project teleconferences and meetings. A Public 
Involvement Panel will be established in the north west 
of England. This will comprise of six to eight members, 
co-chaired by the PPI co-applicants. The members have 
personal experience of family members living with 
dementia in care homes. The panel members will work 
alongside the research team to assist in different areas 
of research including reviewing participant information 
sheets and other documentation, five face-to-face meet-
ings are proposed during the study, and communication 
between meetings will be by regular updates. There will 
also be PPI representation on the research advisory group 
and Trial Steering Committee (TSC).
Monitoring and trial management
For this research population there is a relatively high risk of 
death, hospitalisation or progression of disease for partici-
pants during the course of the study but which are not antic-
ipated to be related to the receipt of the intervention. This 
level and type of risk will be treated as an acceptable risk 
for the purposes of the study and will not constitute adverse 
events or serious adverse events unless concern is raised by 
anyone associated with the study that these events could be 
directly related to participation in this study.
The Trial Management Group is responsible for (1) 
protocol completion, (2) obtaining ethical approval for 
phases I and II, (3) obtaining ethical approval for phase III 
plus nursing home approval process; (4) appointing and 
facilitating the TSC; and (5) working with the dissemina-
tion partners. The group will meet for a ‘kick off’ meeting 
face to face at the start of the project. Thereafter there will 
be monthly teleconferences and twice yearly face-to-face 
meetings. The TSC, with an independent chair, will provide 
overall supervision of the trial including trial progress and 
participant safety. Membership will be drawn from experts 
in health services research, nursing home research and PPI. 
They will meet prior to the start of the trial phase and then 
twice during the second year of the project. The TSC will 
have the role of a traditional Data Monitoring Committee 
as this a feasibility study with a low-risk intervention. A TSC 
charter based on the guidelines published by the National 
Institute for Health Research  (NIHR) will be used to iden-
tify the remit of the TSC. An International Advisory Group 
will also be established to provide external expert advice on 
the overall progress of the study. There is a data manage-
ment plan (held by the sponsor) which outlines data storage 
periods and future access to data.
dIsCussIon
This protocol describes the Namaste Care programme 
for residents with advanced dementia who are living in 
nursing care homes. The Namaste Care programme is a 
multisensory care programme conducted on a daily basis 
in a group setting. This study will provide information 
on implementation, cost and acceptability of a defined 
intervention. In addition, this study will provide infor-
mation on usefulness, practicality and acceptability of 
the selected outcome measures and processes used in 
this study. In conclusion, the findings of this study will 
inform future research on the Namaste Care programme 
in nursing care homes.
EthICs And dIssEMInAtIon
The study has been approved by the Wales Research Ethics 
Committee 5 (ref: 17/WA/0378; V.04. 9 February 2018). 
As resident’s eligible for the study will lack capacity to 
consent, consent for residents will be taken from either 
a personal consultee or a nominated consultee following 
the Mental Capacity Act (2005) guidance.28 45 A proce-
dure for reporting issues of concern in the care setting 
has been written.
The following dissemination channels will be used: 
a project website (http://www. namastetrial. org. uk), a 
leaflet summarising the study, summaries of findings, 
publications/articles for general as well as scientific media 
and social media such as Twitter (@NamasteResearch). 
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All publications will follow the relevant reporting guide-
lines for reviews and trials.46
twitter @NamasteResearch
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